Cited by 20Reproductive Health and ContraceptionHealth Literacy and Information AccessibilityPharmacy and Medical Practices

Comprehension of an over-the-counter drug facts label prototype for a mifepristone and misoprostol medication abortion product

Open access
Biggs, M. Antonia, Ehrenreich, Katherine, Morris, Natalie, Blanchard, Kelly, Bustamante, Claudie Kiti, Choimorrow, Sung Yeon, Hauser, Debra, Hernandez, Yamani +9 more·2022·Obstetrics & Gynecology

Abstract

OBJECTIVE: To develop a drug facts label prototype for a combination mifepristone and misoprostol product and to conduct a label-comprehension study to assess understanding of key label concepts. METHODS: We followed U.S. Food and Drug Administration guidance, engaged a multidisciplinary group of experts, and conducted cognitive interviews to develop a drug facts label prototype for medication abortion. To assess label comprehension, we developed 11 primary and 13 secondary communication objectives related to indications for use, eligibility, dosing regimen, contraindications, warning signs, side effects, and recognizing the risk of treatment failure, with corresponding target performance thresholds (80-90% accuracy). We conducted individual structured video interviews with people with a uterus aged 12-49 years, recruited through social media. Participants reviewed the drug facts label and responded to questions to assess their understanding of each communication objective. After transcribing and coding interviews, we estimated the proportion of correct responses and exact binomial 95% CIs by age and literacy group. RESULTS: We interviewed 851 people (of 1,507 people scheduled); responses from 844 were eligible for analysis, and 35.7% (n=301) of participants were aged 12-17 years. The overall sample met performance criteria for 10 of the 11 primary communication objectives (93-99% correct) related to indications for use, eligibility for use, the dosing regimen, and contraindications; young people met nine and people with limited literacy met eight of the 11 performance criteria. Only 79% (95% CI 0.76-0.82) of the overall sample understood to contact a health care professional if little or no bleeding occurred soon after taking misoprostol, not meeting the prespecified threshold of 85.0%. CONCLUSION: Overall, high levels of comprehension suggest that people can understand most key drug facts label concepts for a medication abortion product without clinical supervision and recommend minor modifications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/aog.0000000000004757

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Biggs, M. A., Ehrenreich, K., Morris, N., Blanchard, K., Bustamante, C. K., Choimorrow, S. Y., Hauser, D., Hernandez, Y., Kapp, N., Kromenaker, T., Moayedi, G., Perritt, J. B., Ralph, L., Raymond, E. G., Valladares, E. S., White, K., & Grossman, D.
Affiliations
Advocates for Youth (US)
Corresponding author
Biggs, M. Antonia
Venue
Obstetrics & Gynecology
Published
2022-05-02
Volume
139
Issue
6
Pages
1111-1122
ISSN
0029-7844 (ISSN-L)
OpenAlex
W4282039506
Cited by
20
References
30
Citations by year
2026: 5 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 2
FWCI
3.31
Type
journal article
Language
en
Open access
Locations
  • Obstetrics and Gynecology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD052163)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Health Professions › General Health Professions › Health Literacy and Information Accessibility
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
Keywords
abortion pills, mifepristone, misoprostol, label comprehension, health communication, cognitive interviewing, youth, low literacy, dosing regimen, contraindications
MeSH terms
Abortion, Induced, Adolescent, Nonprescription Drugs, Female, Humans, Pregnancy, Mifepristone, Misoprostol, Comprehension

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review